Stock Price
469.90
Daily Change
0.41 0.09%
Monthly
-4.04%
Yearly
32.52%
Q1 Forecast
455.03

United Therapeutics reported $7.16 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 7.07 6.19 Feb/25 2026
FY2025Q3 Sep/2025 7.16 7.43 6.39 Oct/29 2025
FY2025Q2 Jun/2025 6.41 7.35 5.85 Jul/30 2025
FY2025Q1 Mar/2025 6.63 6.53 6.17 Apr/30 2025
FY2024Q4 Dec/2024 6.19 6.68 4.36 Feb/26 2025




Eps Change Date
Amarin USD 0.08 0.11 Sep/2025
Ardelyx USD 0 0.08 Sep/2025
Baxter International USD 0.69 0.1 Sep/2025
Bayer EUR 0.57 0.66 Sep/2025
Biogen USD 4.81 0.66 Sep/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Gilead Sciences USD 2.47 0.46 Sep/2025
GlaxoSmithKline GBP 0.55 0.08 Sep/2025
Halozyme Therapeutics USD 1.72 0.18 Sep/2025
Insmed USD -1.75 0.05 Sep/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
J&J USD 2.46 0.34 Dec/2025
Moderna USD -0.51 1.62 Sep/2025
Pfizer USD 0.87 0.09 Sep/2025
PTC Therapeutics USD 0.2 1.03 Sep/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
Teva Pharmaceutical Industries USD 2.98 0.43 Dec/2025
United Therapeutics USD 7.16 0.75 Sep/2025
Vertex Pharmaceuticals USD 4.8 0.28 Sep/2025